Philip Morris’s ZYN Nicotine pouch isn’t safe

FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn can help adult smokers cut back or quit cigarettes.
ZYN Nicotine Pouches Receive FDA Marketing Approval
The FDA has authorized 20 ZYN nicotine pouch products from Philip Morris International (NYSE: PM), marking the first approval of its kind. After a thorough review, the FDA confirmed these products meet public health standards and present lower risks than cigarettes and smokeless tobacco.
FDA authorization of ZYN pouches ‘slight positive’ for Philip Morris, says UBS
The FDA on Thursday authorized the marketing of 20 ZYN nicotine pouches, including flavors ... The firm, which has a Sell rating and $105 price target on the shares, says U.S. ZYN is 7% of ...
Zyn nicotine pouches can be marketed in the U.S., the FDA says. What does this mean?
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious health conditions compared to cigarettes and smokeless tobacco products.
FDA authorizes Zyn nicotine pouches, cites lower risk than cigarettes
The Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, marking the first such move by the regulator for the fast-growing nicotine pouches segment. The ...
Philip Morris’s Zyn nicotine pouch isn’t safe, but FDA gives OK to marketing it
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine pouches.
Philip Morris Stock Rises On FDA Approval For Zyn Nicotine Pouches: Retail’s Upbeat
Shares of Philip Morris International Inc. ($PM) rose more than 1% on Thursday after the US Food and Drug Administration (FDA) authorized marketing of its Zyn nicotine pouch products, lifting retail sentiment.
Philip Morris stock rises on FDA's first nicotine pouch approval
Shares of Philip Morris International Inc. (NYSE:PM) rose 1% following the U.S. Food and Drug Administration's (FDA) authorization of 20 ZYN nicotine pouch products for marketing. The FDA's decision,
CBS News2d
What is Zyn? FDA OKs sales, but health concerns of the controversial nicotine pouches remain
It's called Zyn, a brand of nicotine pouches that have gained popularity, especially among younger demographics. Some proponents of the pouches say it gives them a rush, while others hope it'll ...
fox17online2d
Doctor urges caution after FDA approves Zyn nicotine pouches
(WXMI) — The Food and Drug Administration (FDA) has authorized the sale of Zyn nicotine pouches as a way to help smokers kick the habit. Ten flavors were given the green light, including menthol ...
The Boston Globe3d
FDA approves sales of Zyn nicotine pouches, citing health benefits for adult smokers
WASHINGTON — Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit ...
New York Post2d
FDA backs Zyn nicotine pouches, citing health benefits for adult smokers
WASHINGTON — Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit ...